Bone Microarchitecture in Women With and Without Fracture
mMRI
1 other identifier
observational
78
1 country
2
Brief Summary
Osteoporosis is a common disorder of compromised bone strength causing 40-50% of women and \~25% of men to sustain fragility fractures during their lifetime. The reduction of bone strength in osteoporotic people results from loss of bone density and deterioration of bone quality. Bone quality is a complex amalgamation including macro- and micro-architecture, mineralization, turnover and damage accumulation. Currently, medications to reduce fracture risk are prescribed primarily on the basis of bone mineral density (BMD) measurement. Unfortunately, currently available BMD measurement technologies do not detect the aforementioned properties of bone quality; as such, less than half of individuals who sustain osteoporotic fractures are classified as "osteoporotic" by currently available diagnostic tools. Clearly, measures to enhance identification of those at high fracture risk are needed. High-resolution magnetic resonance imaging (HR-MRI) technology, such as that provided by MicroMRI, Inc., has outstanding potential to be such a tool. Therefore, our long-term goal is to evaluate and optimize the use of HR-MRI in fracture risk prediction; this pilot work is an essential step in attaining this goal. This research will investigate 72 postmenopausal women with normal or osteopenic BMD by dual-energy x-ray absorptiometry (DXA), 36 with prior low-trauma fractures will be compared with 36 age-, race- and BMD matched women without fracture. We hypothesize that 1.) Women with fractures will have evidence of microarchitectural deterioration on HR-MRI and 2.) Newly developed, more rapid MRI sequences designed at the UW will provide similar trabecular microstructure information more rapidly than the currently used, albeit investigational, technology produced by MicroMRI, Inc. Our specific aims are to a) Evaluate differences in MicroMRI parameters of trabecular microstructure (bone volume fraction, trabecular thickness, surface/curve ratio and erosion index) between age-, race- and BMD-matched postmenopausal women with and without fracture; b.) Correlate T2\* relaxation time (a rapid indirect MRI measure of trabecular density and microstructure) with BMD measured by DXA, and microstructural parameters measured by MicroMRI. As an exploratory aim we will investigate HR-MRI parameters of trabecular microstructure obtained using a newly developed, rapid MRI sequence referred to as IDEAL-FSE with parameters obtained using the currently available MicroMRI, Inc. sequence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2008
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 12, 2010
CompletedFirst Posted
Study publicly available on registry
January 14, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedOctober 5, 2015
July 1, 2010
1.6 years
January 12, 2010
October 1, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate difference in MicroMRI parameters of trabecular microstructure (bone volume, surface/curve ratio and erosion index) between age-, race- and BMD-matched postmenopausal women with and without fracture.
18 months
Secondary Outcomes (1)
Correlate T2* relaxation time (a rapid indirect MRI measure of trabecular density and microstructure) with BMD measured by DXA, and microstructural parameters measured by MicroMRI.
18 months
Study Arms (2)
Fracture
Subjects experiencing a prior osteoporotic fracture.
Control
These will be age and bone density matched controls to the fracture group.
Eligibility Criteria
Seventy-two postmenopausal volunteers age ≥ 50 years will be recruited from existing databases of \~3500 women with expressed interested in research. All will have normal BMD or osteopenia (T-score \> -2.5 at the L1-4 spine, proximal femur and 1/3rd radius) by DXA. Thirty-six will have sustained a "fragility" fracture of the spine, hip or wrist, defined as a fracture occurring with everyday activities including a fall from standing height or less. Historical radiographic documentation of fracture will be obtained. Thirty-six women without fracture will serve as age- race- and BMD-matched controls. Age will be matched to within 6 months; BMD in grams/cm2 at the non-dominant ultra-distal radius will be matched to within 5%.
You may qualify if:
- Postmenopausal women volunteers age ≥ 50 years
- normal BMD or osteopenia (T-score \> -2.5 at the L1-4 spine, proximal femur and 1/3rd radius) by DXA.
- sustained a "fragility" fracture of the spine, hip or wrist, defined as a fracture occurring with everyday activities including a fall from standing height or less.
- Historical radiographic documentation of fracture will be obtained.
- Criteria as defined above without prior fracture, age and bone density matching a participant in the fracture group
You may not qualify if:
- metabolic bone disease
- malignancy
- renal failure
- use of medications which alter bone turnover
- diseases/conditions leading to the non-dominant arm disuse
- contraindications to MRI.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Wisconsin Hospitals and Clinics
Madison, Wisconsin, 53705, United States
University of Wisconsin Osteoporosis Clinical and Research Program
Madison, Wisconsin, 53705, United States
Biospecimen
Blood samples are being collected to obtain chemistry panel and test related to skeletal status. These samples will not be retained or stored after these analyses are completed.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Kijowski, MD
University of Wisconsin Department of Radiology
- STUDY DIRECTOR
Neil C Binkley, MD
University of Wisconsin Osteoporosis Clinical Research Center
- STUDY DIRECTOR
Michael J Tuite, MD
University of Wisconsin Department of Radiology
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2010
First Posted
January 14, 2010
Study Start
October 1, 2008
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
October 5, 2015
Record last verified: 2010-07